A Modern View on the Problem of Gastrointestinal Damage During the Use of Nonsteroidal Anti-Inflammatory Drugs: Pathogenesis of Gastroenteropathies; Risk Factors; Gastroenteroprotective Agents
Lviv clinical bulletin · 30.06.2026 · (2 (54)) · 60-66
DOI: 10.25040/lkv2026.02.060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lviv clinical bulletin, online erschienen am 30.06.2026. Verfasst von I. Prysiazhniuk und 2 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Introduction
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. The purpose of their use is to suppress the synthesis of inflammatory mediators and the development of its manifestations. These drugs cause about 20.0 % of all side effects of pharmacotherapy in England, 25.0 % in the United States of America and 40.0 % in Ukraine; 90.0 % of them are gastroduodenal complications. The aim of the study was to present a view on the problem of the gastrointestinal injuries pathogenesis during the use of nonsteroidal anti-inflammatory drugs, risk factors for their occurrence, and means of gastroenteroprotection based on the published research results analysis of modern Ukrainian and foreign scientists. Materials and methods. A bibliosemantic search for scientific articles on the selected topic published in scientific journals indexed in the scientometric databases SCOPUS, Web of Science, Pubmed and deposited in the electronic archive of the V. I. Vernadsky National Library of Ukraine was conducted.
Results
Nonsteroidal anti-inflammatory drugs are among the most popular medications for pain relief. Long-term treatment with these drugs leads to damage to the protective mucosal-hydrocarbonate barrier of the stomach and duodenum. The classic systemic effect is primarily a decrease in the production of prostaglandins in the gastric mucosa, by inhibiting the activity of cyclooxygenase type 1. Systemic COX blockade additionally contributes to a decrease in microvascular blood flow, and the influence of aggressive components of gastric contents enhances these changes, which ultimately leads to the development of inflammation, erosions and ulcerative defects of the mucous membrane. Current measures to reduce the risk of gastrointestinal events with oral NSAID therapy include the concomitant use of drugs such as proton pump inhibitors and H2 histamine receptor blockers or synthetic prostaglandin analogues.
Conclusions
Among the most common side effects of nonsteroidal anti-inflammatory drugs are harmful effect on the gastrointestinal system due primarily to a decrease in the production of prostaglandins in the gastric mucosa, through inhibition of the activity of cyclooxygenase type 1, interaction with phospholipids of cell membranes and disruption of oxidative phosphorylation processes in mitochondria. Risk factors for gastrointestinal erosive-ulcerative changes include such conditions as previous history, high doses of nonsteroidal anti-inflammatory drugs, Helicobacter pylori infection and concomitant use of certain antiplatelet drugs. To minimize the occurrence of adverse events, nonsteroidal anti-inflammatory drugs (NSAIDs) should be administered at the lowest effective dose for the shortest necessary duration. When indicated by elevated gastrointestinal risk, concomitant gastroprotective agents should be recommended to prevent gastropathy and protect the stomach mucosa. These side effects can be mitigated using proton pump inhibitors, H2-histamine receptor blockers, or synthetic prostaglandin analogues.
Zitieren
APA
Prysiazhniuk, I., Prysyazhnyuk, V., & Dynys, O. (2026). A Modern View on the Problem of Gastrointestinal Damage During the Use of Nonsteroidal Anti-Inflammatory Drugs: Pathogenesis of Gastroenteropathies; Risk Factors; Gastroenteroprotective Agents. Lviv clinical bulletin, 60-66. https://doi.org/10.25040/lkv2026.02.060
Vancouver
Prysiazhniuk I, Prysyazhnyuk V, Dynys O. A Modern View on the Problem of Gastrointestinal Damage During the Use of Nonsteroidal Anti-Inflammatory Drugs: Pathogenesis of Gastroenteropathies; Risk Factors; Gastroenteroprotective Agents. Lviv clinical bulletin. 2026:60-66. doi:10.25040/lkv2026.02.060
BibTeX
@article{Prysiazhniuk2026,
author = {Prysiazhniuk, I. and Prysyazhnyuk, V. and Dynys, O.},
title = {A Modern View on the Problem of Gastrointestinal Damage During the Use of Nonsteroidal Anti-Inflammatory Drugs: Pathogenesis of Gastroenteropathies; Risk Factors; Gastroenteroprotective Agents},
journal = {Lviv clinical bulletin},
year = {2026},
number = {2 (54)},
pages = {60--66},
doi = {10.25040/lkv2026.02.060}
}
EUVIMED